Barbara-jean Anne Bormann-kennedy
Director at Xeris Biopharma Holdings, Inc. (XERS)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $204K
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Jun 5SEC | XERSXeris Biopharma Holdings, Inc. | Sell Plan | 16,000126,500 held (−11%) | $6.09 | $97K | +69.3% |
| Dec 15SEC | XERSXeris Biopharma Holdings, Inc. | Sell Plan | 15,000142,500 held (−10%) | $7.09 | $106K | +45.4% |
- Sell
Director Barbara-jean Anne Bormann-kennedy sold $97K of XERS at $6.09 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Barbara-jean Anne Bormann-kennedy sold $106K of XERS at $7.09 — pre-scheduled 10b5-1 plan sale.